Compounded medication for patients with rare diseases

by Marc Dooms, Maria Carvalho
Published 2018-01-01

Orphan Drugs, Compounded Medication and Pharmaceutical Commons

by Kim Hendrickx, Marc Dooms
Published 2021-09-01

Off-label use of orphan medicinal products: a Belgian qualitative study

by Marc Dooms, David Cassiman, Steven Simoens
Published 2016-10-01

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

by Liese Vandeborne, Eline van Overbeeke, Marc Dooms, Birgit De Beleyr, Isabelle Huys
Published 2019-05-01

Clinical Research in Neonates: Redesigning the Informed Consent Process in the Digital Era

by Evelien De Sutter, Birte Coopmans, Femke Vanendert, Marc Dooms, Karel Allegaert, Karel Allegaert, Karel Allegaert, Pascal Borry, Isabelle Huys
Published 2021-09-01

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice

by Rosanne Janssens, Eline van Overbeeke, Lotte Verswijvel, Lissa Meeusen, Carolien Coenegrachts, Kim Pauwels, Marc Dooms, Hilde Stevens, Steven Simoens, Isabelle Huys
Published 2018-10-01

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

by Ewa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, Rafał Bobiński, Jacek Siwiec, Dimitra Panteli, Dimitra Panteli, Dimitra Panteli, Helene Eckhardt, Helene Eckhardt, Helene Eckhardt, Steven Simoens, Antònia Agusti, Antònia Agusti, Marc Dooms, Andrzej Pilc, Andrzej Pilc
Published 2019-11-01